ATLANTA, GA – – (Globe Newswire – February 3, 2026) – – A shareholder class action lawsuit has been filed against Picard Medical, Inc. (“Picard” or the “Company”) (NASDAQ: PMI). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts, including allegations that: (1) Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) Picard’s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.

If you purchased Picard shares between September 2, 2025 and October 31, 2025, and experienced a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by visiting the firm’s website at www.holzerlaw.com/case/picard-medical/ for more information.

The deadline to ask the court to be appointed lead plaintiff in the case is April 3, 2026.